BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25266480)

  • 21. Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing.
    Kato T; Morisada N; Nagase H; Nishiyama M; Toyoshima D; Nakagawa T; Maruyama A; Fu XJ; Nozu K; Wada H; Takada S; Iijima K
    Brain Dev; 2015 Oct; 37(9):911-5. PubMed ID: 25819767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and electroencephalographic features in patients with CDKL5 mutations: two new Italian cases and review of the literature.
    Pintaudi M; Baglietto MG; Gaggero R; Parodi E; Pessagno A; Marchi M; Russo S; Veneselli E
    Epilepsy Behav; 2008 Feb; 12(2):326-31. PubMed ID: 18063413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy.
    Zhang Q; Li J; Zhao Y; Bao X; Wei L; Wang J
    Clin Genet; 2017 May; 91(5):717-724. PubMed ID: 27779742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutations.
    Moseley BD; Dhamija R; Wirrell EC; Nickels KC
    Pediatr Neurol; 2012 Feb; 46(2):101-5. PubMed ID: 22264704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy.
    Fichou Y; Bieth E; Bahi-Buisson N; Nectoux J; Girard B; Chelly J; Chaix Y; Bienvenu T
    Neurology; 2009 Jul; 73(1):77-8; author reply 78. PubMed ID: 19564592
    [No Abstract]   [Full Text] [Related]  

  • 26. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy.
    Rosas-Vargas H; Bahi-Buisson N; Philippe C; Nectoux J; Girard B; N'Guyen Morel MA; Gitiaux C; Lazaro L; Odent S; Jonveaux P; Chelly J; Bienvenu T
    J Med Genet; 2008 Mar; 45(3):172-8. PubMed ID: 17993579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
    Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
    Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
    Mercimek-Mahmutoglu S; Patel J; Cordeiro D; Hewson S; Callen D; Donner EJ; Hahn CD; Kannu P; Kobayashi J; Minassian BA; Moharir M; Siriwardena K; Weiss SK; Weksberg R; Snead OC
    Epilepsia; 2015 May; 56(5):707-16. PubMed ID: 25818041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDKL5 mutations as a cause of severe epilepsy in infancy: clinical and electroencephalographic long-term course in 4 patients.
    Jähn J; Caliebe A; von Spiczak S; Boor R; Stefanova I; Stephani U; Helbig I; Muhle H
    J Child Neurol; 2013 Jul; 28(7):937-41. PubMed ID: 22832775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex mosaic CDKL5 deletion with two distinct mutant alleles in a 4-year-old girl.
    Boutry-Kryza N; Ville D; Labalme A; Calender A; Dupont JM; Touraine R; Edery P; des Portes V; Sanlaville D; Lesca G
    Am J Med Genet A; 2014 Aug; 164A(8):2025-8. PubMed ID: 24715584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel p.Arg970X mutation in the last exon of the CDKL5 gene resulting in late-onset seizure disorder.
    Psoni S; Willems PJ; Kanavakis E; Mavrou A; Frissyra H; Traeger-Synodinos J; Sofokleous C; Makrythanassis P; Kitsiou-Tzeli S
    Eur J Paediatr Neurol; 2010 Mar; 14(2):188-91. PubMed ID: 19428276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.
    Archer HL; Evans J; Edwards S; Colley J; Newbury-Ecob R; O'Callaghan F; Huyton M; O'Regan M; Tolmie J; Sampson J; Clarke A; Osborne J
    J Med Genet; 2006 Sep; 43(9):729-34. PubMed ID: 16611748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett syndrome.
    Sartori S; Di Rosa G; Polli R; Bettella E; Tricomi G; Tortorella G; Murgia A
    Am J Med Genet A; 2009 Feb; 149A(2):232-6. PubMed ID: 19161156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy.
    Gokben S; Onay H; Yilmaz S; Atik T; Serdaroglu G; Tekin H; Ozkinay F
    Acta Neurol Belg; 2017 Mar; 117(1):131-138. PubMed ID: 27734276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.
    Allou L; Julia S; Amsallem D; El Chehadeh S; Lambert L; Thevenon J; Duffourd Y; Saunier A; Bouquet P; Pere S; Moustaïne A; Ruaud L; Roth V; Jonveaux P; Philippe C
    Clin Genet; 2017 Mar; 91(3):431-440. PubMed ID: 27062609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical phenotype of 5 females with a CDKL5 mutation.
    Stalpers XL; Spruijt L; Yntema HG; Verrips A
    J Child Neurol; 2012 Jan; 27(1):90-3. PubMed ID: 21765152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epileptic encephalopathy and atypical Rett syndrome with mutations in CDKL5: clinical and molecular characterization of two Brazilian patients.
    Ermel EL; Carneiro LC; Souza CF; Crippa AC; Sanseverino MT; Raskin S
    Arq Neuropsiquiatr; 2013 Jun; 71(6):414-5. PubMed ID: 23828526
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of Hungarian patients with Rett syndrome phenotype for MECP2, CDKL5 and FOXG1 gene mutations.
    Hadzsiev K; Polgar N; Bene J; Komlosi K; Karteszi J; Hollody K; Kosztolanyi G; Renieri A; Melegh B
    J Hum Genet; 2011 Mar; 56(3):183-7. PubMed ID: 21160487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene.
    Bahi-Buisson N; Girard B; Gautier A; Nectoux J; Fichou Y; Saillour Y; Poirier K; Chelly J; Bienvenu T
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):202-7. PubMed ID: 19455595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.